KORU Medical Systems' (KRMD) "Sell (D-)" Rating Reiterated at Weiss Ratings

Key Points

• KORU Medical Systems' stock has been given a persistent "sell (D-)" rating by Weiss Ratings, signaling ongoing concerns among analysts.
• The company's shares recently increased by 6.6%, opening at $4.19, while its market cap stands at $193.75 million.
• KORU Medical reported $0.01 earnings per share, exceeding analysts' estimates and achieving revenue of $10.20 million for the quarter.

KORU Medical Systems (NASDAQ:KRMD - Get Free Report)'s stock had its "sell (d-)" rating restated by research analysts at Weiss Ratings in a note issued to investors on Wednesday,Weiss Ratings reports.

KORU Medical Systems Stock Up 6.6%

Shares of NASDAQ:KRMD opened at $4.19 on Wednesday. The stock's 50-day moving average price is $3.99 and its two-hundred day moving average price is $3.32. The company has a current ratio of 2.91, a quick ratio of 2.25 and a debt-to-equity ratio of 0.01. KORU Medical Systems has a 12-month low of $1.86 and a 12-month high of $5.05. The firm has a market cap of $193.75 million, a price-to-earnings ratio of -46.56 and a beta of 0.49.

KORU Medical Systems (NASDAQ:KRMD - Get Free Report) last issued its quarterly earnings results on Wednesday, August 6th. The company reported $0.01 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.03) by $0.04. KORU Medical Systems had a negative return on equity of 26.77% and a negative net margin of 12.24%.The firm had revenue of $10.20 million for the quarter, compared to analyst estimates of $9.46 million. On average, research analysts forecast that KORU Medical Systems will post -0.13 EPS for the current year.

Institutional Inflows and Outflows

Hedge funds and other institutional investors have recently added to or reduced their stakes in the company. Police & Firemen s Retirement System of New Jersey acquired a new position in KORU Medical Systems in the second quarter valued at $30,000. Lazard Asset Management LLC acquired a new position in KORU Medical Systems in the second quarter valued at $59,000. Acadian Asset Management LLC acquired a new position in KORU Medical Systems in the first quarter valued at $63,000. Intech Investment Management LLC acquired a new position in KORU Medical Systems in the second quarter valued at $73,000. Finally, Invesco Ltd. acquired a new position in KORU Medical Systems in the second quarter valued at $80,000. Institutional investors and hedge funds own 58.60% of the company's stock.

KORU Medical Systems Company Profile

KORU Medical Systems, Inc develops and manufactures medical devices and supplies in the United States and internationally. It offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases, chronic inflammatory demyelinating polyneuropathy, and paroxysmal nocturnal hemoglobinuria.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.